Literature DB >> 16477867

Tuberculosis: current trends in diagnosis and treatment.

A K Bello1, C H Njoku, A K Njoku.   

Abstract

Among communicable diseases, tuberculosis (TB) is the second leading cause of death worldwide, killing nearly 2 million people each year. It is estimated that about one-third of the world population are infected with TB (2 billion people) and about 10% of this figure will progress to disease state. Most cases are in the less-developed countries of the world. Tuberculosis incidence has been on the increase in Africa, mainly as a result of the burden of HIV infection. Definitive diagnosis of tuberculosis remains based on culture for Mycobacterium tuberculosis, but rapid diagnosis of infectious tuberculosis by simple sputum smear for acid fast bacilli remains an important tool, as more rapid molecular techniques are being developed. Treatment with several drugs for 6 months or more can cure more than 95% of patients. Direct observation of treatment, a component of the recommended five-element DOTS strategy, is judged to be the standard of care by most authorities. Currently only a third of cases worldwide are treated using this approach. There may be need to modify the treatment modalities especially with the choice of drugs and duration of therapy when TB infection occurs in special situation like pregnancy, liver disease, renal failure or even in coexistence with HlV/AIDS or the drug resistant state.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16477867

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  3 in total

1.  Lowenstein-Jensen selective medium for reducing contamination in Mycobacterium tuberculosis culture.

Authors:  Kennedy Kassaza; Patrick Orikiriza; Augusto Llosa; Joel Bazira; Dan Nyehangane; Anne-Laure Page; Yap Boum
Journal:  J Clin Microbiol       Date:  2014-04-30       Impact factor: 5.948

2.  Patho-TB test for the rapid diagnosis of pulmonary tuberculosis.

Authors:  Roya Alavi-Naini; Maliheh Metanat; Ebrahim Alijani; Hassan Mozaffar
Journal:  J Res Med Sci       Date:  2009-09       Impact factor: 1.852

3.  Evaluation of CD4+ CD25+ FoxP3+ Regulatory T cells and FoxP3 and CTLA-4 gene Expression in Patients wwith Newly Diagnosed Tuberculosis in Northeast of Iran.

Authors:  Roghayeh Ghazalsofala; Seyed Abdolrahim Rezaee; Houshang Rafatpanah; Rosita Vakili; Kiarash Ghazvini; Fatemeh Heidarnejad; Somaye Sobhani; Narges Valizadeh; Marayam Azami; Marzieh Rahimzadegan; Amir Asnaashari
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.